Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 22912940)

1.

Prevalence and association of microalbuminuria in essential hypertensive patients.

Poudel B, Yadav BK, Nepal AK, Jha B, Raut KB.

N Am J Med Sci. 2012 Aug;4(8):331-5. doi: 10.4103/1947-2714.99501.

2.

Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study.

Sciarretta S, Pontremoli R, Rosei EA, Ambrosioni E, Costa V, Leonetti G, Pessina AC, Trimarco B, Francione V, Tocci G, Musumeci MB, De Siati L, Ferrucci A, Deferrari G, Volpe M.

J Hypertens. 2009 Feb;27(2):410-7.

PMID:
19226711
3.

Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.

Kato T, Horio T, Tomiyama M, Kamide K, Nakamura S, Yoshihara F, Nakata H, Nakahama H, Kawano Y.

Nephrol Dial Transplant. 2007 Mar;22(3):911-6. Epub 2006 Dec 1.

4.

Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension.

Cerasola G, Cottone S, Mulé G, Nardi E, Mangano MT, Andronico G, Contorno A, Li Vecchi M, Galione P, Renda F, Piazza G, Volpe V, Lisi A, Ferrara L, Panepinto N, Riccobene R.

J Hypertens. 1996 Jul;14(7):915-20.

PMID:
8818932
5.

Male erectile dysfunction and microalbuminuria in adult nigerians with essential hypertension.

Busari OA, Opadijo OG, Olarewaju TO, Oladosu YO.

N Am J Med Sci. 2013 Jan;5(1):32-6. doi: 10.4103/1947-2714.106191.

6.

Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria.

Huang PH, Huang SS, Chen YH, Lin CP, Chiang KH, Chen JS, Tsai HY, Lin FY, Chen JW, Lin SJ.

J Hypertens. 2010 Aug;28(8):1655-65. doi: 10.1097/HJH.0b013e32833a4d0a.

PMID:
20520578
7.

Prevalence of microalbuminuria and relationship to the risk of cardiovascular disease in the Japanese population.

Tomura S, Kawada K, Saito K, Lin YL, Endou K, Hirano C, Yanagi H, Tsuchiya S, Shiba K.

Am J Nephrol. 1999;19(1):13-20.

PMID:
10085444
8.

The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension.

Pontremoli R, Sofia A, Tirotta A, Ravera M, Nicolella C, Viazzi F, Bezante GP, Borgia L, Bobola N, Ravazzolo R, Sacchi G, Deferrari G.

J Am Soc Nephrol. 1996 Dec;7(12):2550-8.

9.

[Microalbuminuria is associated with a fourfold increased risk of ischemic heart disease among hypertensive patients].

Jensen JS, Feldt-Rasmussen BF, Strandgaard S, Schroll M, Borch-Johnsen K.

Ugeskr Laeger. 2002 Aug 5;164(32):3773-7. Danish.

PMID:
12362612
10.

Microalbuminuria in patients with rheumatoid arthritis.

Pedersen LM, Nordin H, Svensson B, Bliddal H.

Ann Rheum Dis. 1995 Mar;54(3):189-92.

11.

[Microalbuminuria in essential hypertension: of limited value as an indicator of patients with a high risk for complications].

Stehouwer CD, Jager A, Donker AJ.

Ned Tijdschr Geneeskd. 1997 Aug 23;141(34):1649-53. Review. Dutch.

PMID:
9543776
12.

Microalbuminuria and subclinical cerebrovascular damage in essential hypertension.

Ravera M, Ratto E, Vettoretti S, Viazzi F, Leoncini G, Parodi D, Tomolillo C, Del Sette M, Maviglio N, Deferrari G, Pontremoli R.

J Nephrol. 2002 Sep-Oct;15(5):519-24.

PMID:
12455718
13.

Prevalence and risk factors of microalbuminuria in Thai nondiabetic hypertensive patients.

Gojaseni P, Phaopha A, Chailimpamontree W, Pajareya T, Chittinandana A.

Vasc Health Risk Manag. 2010 Mar 24;6:157-65.

15.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

16.

Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.

Wachtell K, Olsen MH, Dahlöf B, Devereux RB, Kjeldsen SE, Nieminen MS, Okin PM, Papademetriou V, Mogensen CE, Borch-Johnsen K, Ibsen H.

J Hypertens. 2002 Mar;20(3):405-12.

PMID:
11875307
17.

Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial.

Masson S, Latini R, Milani V, Moretti L, Rossi MG, Carbonieri E, Frisinghelli A, Minneci C, Valisi M, Maggioni AP, Marchioli R, Tognoni G, Tavazzi L; GISSI-HF Investigators.

Circ Heart Fail. 2010 Jan;3(1):65-72. doi: 10.1161/CIRCHEARTFAILURE.109.881805. Epub 2009 Oct 22.

18.

Microalbuminuria, cardiovascular risk factors and cardiovascular morbidity in a British population: the EPIC-Norfolk population-based study.

Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE, Wareham NJ.

Eur J Cardiovasc Prev Rehabil. 2004 Jun;11(3):207-13.

PMID:
15179101
19.
20.

Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension.

Bigazzi R, Bianchi S, Baldari D, Campese VM.

J Hypertens. 1998 Sep;16(9):1325-33.

PMID:
9746120
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk